Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death

Steroids

Volumn 72, Issue 11-12, 2007, Pages 765-777

  Zhou, Jian Hua ^a,b   Yu, David V ^a   Cheng, Jingwei ^a   Shapiro, David J ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Apoptosis; ERK; Estrogen receptor; Tamoxifen

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 HYDROXYTAMOXIFEN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; EPIDERMAL GROWTH FACTOR; ESTROGEN RECEPTOR; FULVESTRANT; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TAMOXIFEN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CELL GROWTH; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

CASPASE 3; CASPASE 9; CELL DEATH; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; ESTRADIOL; ESTROGEN ANTAGONISTS; FLAVONOIDS; HELA CELLS; HUMANS; IMIDAZOLES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PYRIDINES; RECEPTORS, ESTROGEN; TAMOXIFEN; TIME FACTORS;

EID: 34548283101     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2007.06.007     Document Type: Article

References (85)

1. Shang Y., and Brown M. Molecular determinants for the tissue specificity of SERMs. Science 295 (2002) 2465-2468
2. Shiau A.K., Barstad D., Loria P.M., Cheng L., Kushner P.J., Agard D.A., et al. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95 (1998) 927-937
3. Huang H.J., Norris J.D., and McDonnell D.P. Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists. Mol Endocrinol 16 (2002) 1778-1792
4. Smith C.L., and O'Malley B.W. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 25 (2004) 45-71
5. Frasor J., Stossi F., Danes J.M., Komm B., Lyttle C.R., and Katzenellenbogen B.S. Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells. Cancer Res 64 (2004) 1522-1533
6. Simard M., Zhang W., Hinton D.R., Chen T.C., Weiss M.H., Su Y.Z., et al. Tamoxifen-induced growth arrest and apoptosis in pituitary tumor cells in vitro via a protein kinase C-independent pathway. Cancer Lett 185 (2002) 131-138
7. Mandlekar S., and Kong A.N. Mechanisms of tamoxifen-induced apoptosis. Apoptosis 6 (2001) 469-477
8. Hui A.M., Zhang W., Chen W., Xi D., Purow B., Friedman G.C., et al. Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells. Cancer Res 64 (2004) 9115-9123
9. Treon S.P., Teoh G., Urashima M., Ogata A., Chauhan D., Webb I.J., et al. Anti-estrogens induce apoptosis of multiple myeloma cells. Blood 92 (1998) 1749-1757
10. Gasco M., Argusti A., Bonanni B., and Decensi A. SERMs in chemoprevention of breast cancer. Eur J Cancer 41 (2005) 1980-1989
11. Yao K., Lee E.S., Bentrem D.J., England G., Schafer J.I., O'Regan R.M., et al. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice. Clin Cancer Res 6 (2000) 2028-2036
12. Zhang C.C., and Shapiro D.J. Activation of the p38 mitogen-activated protein kinase pathway by estrogen or by 4-hydroxytamoxifen is coupled to estrogen receptor-induced apoptosis. J Biol Chem 275 (2000) 479-486
13. Kushner P.J., Hort E., Shine J., Baxter J.D., and Greene G.L. Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens. Mol Endocrinol 4 (1990) 1465-1473
14. Zhang W., Couldwell W.T., Song H., Takano T., Lin J.H., and Nedergaard M. Tamoxifen-induced enhancement of calcium signaling in glioma and MCF-7 breast cancer cells. Cancer Res 60 (2000) 5395-5400
15. Gauduchon J., Gouilleux F., Maillard S., Marsaud V., Renoir J.M., and Sola B. 4-Hydroxytamoxifen inhibits proliferation of multiple myeloma cells in vitro through down-regulation of c-Myc, up-regulation of p27Kip1, and modulation of Bcl-2 family members. Clin Cancer Res 11 (2005) 2345-2354
16. Zhang C.C., Krieg S., and Shapiro D.J. HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells. Mol Endocrinol 13 (1999) 632-643
17. Obrero M., Yu D.V., and Shapiro D.J. Estrogen receptor-dependent and estrogen receptor-independent pathways for tamoxifen and 4-hydroxytamoxifen-induced programmed cell death. J Biol Chem 277 (2002) 45695-45703
18. Driggers P.H., and Segars J.H. Estrogen action and cytoplasmic signaling pathways. Part II. The role of growth factors and phosphorylation in estrogen signalling. Trends Endocrinol Metab 13 (2002) 422-427
19. Manolagas S.C., and Kousteni S. Perspective: nonreproductive sites of action of reproductive hormones. Endocrinology 142 (2001) 2200-2204
20. Dickson R.B., and Stancel G.M. Estrogen receptor-mediated processes in normal and cancer cells. J Natl Cancer Inst Monogr (2000) 135-145
21. Santen R.J., Song R.X., McPherson R., Kumar R., Adam L., Jeng M.H., et al. The role of mitogen-activated protein (MAP) kinase in breast cancer. J Steroid Biochem Mol Biol 80 (2002) 239-256
22. Zhang Z., Kumar R., Santen R.J., and Song R.X. The role of adapter protein Shc in estrogen non-genomic action. Steroids 69 (2004) 523-529
23. Foster J.S., Fernando R.I., Ishida N., Nakayama K.I., and Wimalasena J. Estrogens down-regulate p27Kip1 in breast cancer cells through Skp2 and through nuclear export mediated by the ERK pathway. J Biol Chem 278 (2003) 41355-41366
24. Thornberry N.A., and Lazebnik Y. Caspases: enemies within. Science 281 (1998) 1312-1316
25. Filomeni G., Aquilano K., Civitareale P., Rotilio G., and Ciriolo M.R. Activation of c-Jun-N-terminal kinase is required for apoptosis triggered by glutathione disulfide in neuroblastoma cells. Free Radic Biol Med 39 (2005) 345-354
26. Carimalo J., Cronier S., Petit G., Peyrin J.M., Boukhtouche F., Arbez N., et al. Activation of the JNK-c-Jun pathway during the early phase of neuronal apoptosis induced by PrP106-126 and prion infection. Eur J Neurosci 21 (2005) 2311-2319
27. Kutuk O., Pedrech A., Harrison P., and Basaga H. Pramanicin induces apoptosis in Jurkat leukemia cells: a role for JNK, p38 and caspase activation. Apoptosis 10 (2005) 597-609
28. Zhang H., Vollmer M., De Geyter M., Durrenberger M., and De Geyter C. Apoptosis and differentiation induced by staurosporine in granulosa tumor cells is coupled with activation of JNK and suppression of p38 MAPK. Int J Oncol 26 (2005) 1575-1580
29. Onyango I.G., Tuttle J.B., and Bennett Jr. J.P. Activation of p38 and N-acetylcysteine-sensitive c-Jun NH2-terminal kinase signaling cascades is required for induction of apoptosis in Parkinson's disease cybrids. Mol Cell Neurosci 28 (2005) 452-461
30. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K., et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22 (2001) 153-183
31. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98 (2001) 13681-13686
32. Carrer H.F., Cambiasso M.J., and Gorosito S. Effects of estrogen on neuronal growth and differentiation. J Steroid Biochem Mol Biol 93 (2005) 319-323
33. Wang J.G., Miyazu M., Xiang P., Li S.N., Sokabe M., and Naruse K. Stretch-induced cell proliferation is mediated by FAK-MAPK pathway. Life Sci 76 (2005) 2817-2825
34. 2 protein promotes human hepatoma cell proliferation through the MAPK/ERK signaling pathway via cellular receptors. Exp Cell Res 305 (2005) 23-32
35. Cho H.M., Choi S.H., Hwang K.C., Oh S.Y., Kim H.G., Yoon D.H., et al. The Src/PLC/PKC/MEK/ERK signaling pathway is involved in aortic smooth muscle cell proliferation induced by glycated LDL. Mol Cells 19 (2005) 60-66
36. Jimenez E., and Montiel M. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells. J Cell Physiol 204 (2005) 678-686
37. Geffroy N., Guedin A., Dacquet C., and Lefebvre P. Cell cycle regulation of breast cancer cells through estrogen-induced activities of ERK and Akt protein kinases. Mol Cell Endocrinol 237 (2005) 11-23
38. Belcher S.M., Le H.H., Spurling L., and Wong J.K. Rapid estrogenic regulation of extracellular signal- regulated kinase 1/2 signaling in cerebellar granule cells involves a G protein- and protein kinase A-dependent mechanism and intracellular activation of protein phosphatase 2A. Endocrinology 146 (2005) 5397-5406
39. Zsarnovszky A., Le H.H., Wang H.S., and Belcher S.M. Ontogeny of rapid estrogen-mediated extracellular signal-regulated kinase signaling in the rat cerebellar cortex: potent nongenomic agonist and endocrine disrupting activity of the xenoestrogen bisphenol A. Endocrinology 146 (2005) 5388-5396
40. Chen Z.H., Na H.K., Hurh Y.J., and Surh Y.J. 4-Hydroxyestradiol induces oxidative stress and apoptosis in human mammary epithelial cells: possible protection by NF-kappaB and ERK/MAPK. Toxicol Appl Pharmacol 208 (2005) 46-56
41. Bryant D.N., Bosch M.A., Ronnekleiv O.K., and Dorsa D.M. 17-Beta estradiol rapidly enhances extracellular signal-regulated kinase 2 phosphorylation in the rat brain. Neuroscience 133 (2005) 343-352
42. Nethrapalli I.S., Tinnikov A.A., Krishnan V., Lei C.D., and Toran-Allerand C.D. Estrogen activates mitogen-activated protein kinase in native, nontransfected CHO-K1, COS-7, and RAT2 fibroblast cell lines. Endocrinology 146 (2005) 56-63
43. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., and Saltiel A.R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J Biol Chem 270 (1995) 27489-27494
44. Simoncini T., Fornari L., Mannella P., Varone G., Caruso A., Garibaldi S., et al. Differential estrogen signaling in endothelial cells upon pulsed or continuous administration. Maturitas 50 (2005) 247-258
45. Scholl F.A., Dumesic P.A., and Khavari P.A. Effects of active MEK1 expression in vivo. Cancer Lett 230 (2005) 1-5
46. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80 (1995) 179-185
47. Hackel P.O., Zwick E., Prenzel N., and Ullrich A. Epidermal growth factor receptors: critical mediators of multiple receptor pathways. Curr Opin Cell Biol 11 (1999) 184-189
48. Zwick E., Hackel P.O., Prenzel N., and Ullrich A. The EGF receptor as central transducer of heterologous signalling systems. Trends Pharmacol Sci 20 (1999) 408-412
49. Atanaskova N., Keshamouni V.G., Krueger J.S., Schwartz J.A., Miller F., and Reddy K.B. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance. Oncogene 21 (2002) 4000-4008
50. Kato S., Kitamoto T., Masuhiro Y., and Yanagisawa J. Molecular mechanism of a cross-talk between estrogen and growth-factor signaling pathways. Oncology 55 Suppl 1 (1998) 5-10
51. Yee D., and Lee A.V. Crosstalk between the insulin-like growth factors and estrogens in breast cancer. J Mammary Gland Biol Neoplasia 5 (2000) 107-115
52. Ignar-Trowbridge D.M., Nelson K.G., Bidwell M.C., Curtis S.W., Washburn T.F., McLachlan J.A., et al. Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci USA 89 (1992) 4658-4662
53. Curtis S.W., Washburn T., Sewall C., DiAugustine R., Lindzey J., Couse J.F., et al. Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. Proc Natl Acad Sci USA 93 (1996) 12626-12630
54. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270 (1995) 1491-1494
55. Rowan B.G., Garrison N., Weigel N.L., and O'Malley B.W. 8-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding protein. Mol Cell Biol 20 (2000) 8720-8730
56. Rowan B.G., Weigel N.L., and O'Malley B.W. Phosphorylation of steroid receptor coactivator-1. Identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway. J Biol Chem 275 (2000) 4475-4483
57. Kato S., Masuhiro Y., Watanabe M., Kobayashi Y., Takeyama K.I., Endoh H., et al. Molecular mechanism of a cross-talk between oestrogen and growth factor signalling pathways. Genes Cells 5 (2000) 593-601
58. Bjornstrom L., and Sjoberg M. Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions. Mol Endocrinol 16 (2002) 2202-2214
59. Thomas P., Pang Y., Filardo E.J., and Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146 (2005) 624-632
60. Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., and Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307 (2005) 1625-1630
61. Filardo E.J., Quinn J.A., Bland K.I., and Frackelton Jr. A.R. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14 (2000) 1649-1660
62. Filardo E.J., Quinn J.A., Frackelton Jr. A.R., and Bland K.I. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 16 (2002) 70-84
63. Stanciu M., and DeFranco D.B. Prolonged nuclear retention of activated extracellular signal-regulated protein kinase promotes cell death generated by oxidative toxicity or proteasome inhibition in a neuronal cell line. J Biol Chem 277 (2002) 4010-4017
64. Park J.S., Qiao L., Gilfor D., Yang M.Y., Hylemon P.B., Benz C., et al. A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes. Mol Biol Cell 11 (2000) 2915-2932
65. Werlen G., Hausmann B., Naeher D., and Palmer E. Signaling life and death in the thymus: timing is everything. Science 299 (2003) 1859-1863
66. Endoh H., Sasaki H., Maruyama K., Takeyama K., Waga I., Shimizu T., et al. Rapid activation of MAP kinase by estrogen in the bone cell line. Biochem Biophys Res Commun 235 (1997) 99-102
67. Oursler M.J. Estrogen regulation of gene expression in osteoblasts and osteoclasts. Crit Rev Eukaryot Gene Expr 8 (1998) 125-140
68. Chen Z., Yuhanna I.S., Galcheva-Gargova Z., Karas R.H., Mendelsohn M.E., and Shaul P.W. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103 (1999) 401-406
69. Singer C.A., Figueroa-Masot X.A., Batchelor R.H., and Dorsa D.M. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 19 (1999) 2455-2463
70. Wong C.W., McNally C., Nickbarg E., Komm B.S., and Cheskis B.J. Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci USA 99 (2002) 14783-14788
71. Kelly M.J., and Levin E.R. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 12 (2001) 152-156
72. Levin E.R. Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol 19 (2005) 1951-1959
73. Barletta F., Wong C.W., McNally C., Komm B.S., Katzenellenbogen B., and Cheskis B.J. Characterization of the interactions of estrogen receptor and MNAR in the activation of cSrc. Mol Endocrinol 18 (2004) 1096-1108
74. Kousteni S., Bellido T., Plotkin L.I., O'Brien C.A., Bodenner D.L., Han L., et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104 (2001) 719-730
75. Razandi M., Oh P., Pedram A., Schnitzer J., and Levin E.R. ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol Endocrinol 16 (2002) 100-115
76. Razandi M., Pedram A., Park S.T., and Levin E.R. Proximal events in signaling by plasma membrane estrogen receptors. J Biol Chem 278 (2003) 2701-2712
77. Hamelers I.H., and Steenbergh P.H. Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells. Endocr Relat Cancer 10 (2003) 331-345
78. Improta-Brears T., Whorton A.R., Codazzi F., York J.D., Meyer T., and McDonnell D.P. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc Natl Acad Sci USA 96 (1999) 4686-4691
79. Perillo B., Sasso A., Abbondanza C., and Palumbo G. 17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol Cell Biol 20 (2000) 2890-2901
80. Simoncini T., Hafezi-Moghadam A., Brazil D.P., Ley K., Chin W.W., and Liao J.K. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407 (2000) 538-541
81. Lin J., and Weiss A. Identification of the minimal tyrosine residues required for linker for activation of T cell function. J Biol Chem 276 (2001) 29588-29595
82. Sakamoto T., Eguchi H., Omoto Y., Ayabe T., Mori H., and Hayashi S. Estrogen receptor-mediated effects of tamoxifen on human endometrial cancer cells. Mol Cell Endocrinol 192 (2002) 93-104
83. Bunone G., Briand P.A., Miksicek R.J., and Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 15 (1996) 2174-2183
84. Lee W.C., Choi C.H., Cha S.H., Oh H.L., and Kim Y.K. Role of ERK in hydrogen peroxide-induced cell death of human glioma cells. Neurochem Res 30 (2005) 263-270
85. Wu R.C., Smith C.L., and O'Malley B.W. Transcriptional regulation by steroid receptor coactivator phosphorylation. Endocr Rev 26 (2005) 393-399